Raymond Evers
- Oncology top 0.2%
- Drug Transport and Resistance Mechanisms 59
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 29
- Drug-Induced Hepatotoxicity and Protection 7
-
- Pharmacological Effects and Toxicity Studies 38
- Biochemistry top 0.5%
- Amino Acid Enzymes and Metabolism 7
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 9
-
- Trypanosoma species research and implications 9
-
- Pediatric Hepatobiliary Diseases and Treatments 6
- Co-authors
- Piet BorstMarcel KoolJan WijnholdsXiaoyan ChuLiesbeth van DeemterKelly BleasbyBalázs SarkadiÉva Bakos
- Journals
- Drug Metabolism and Disposition (17 papers)Clinical Pharmacology & Therapeutics (9 papers)Nucleic Acids Research (6 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Raymond Evers
98 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 5.8k
- Pharmacology 1.8k
- Pediatrics, Perinatology and Child Health 2.7k
- Biochemistry 526
- Infectious Diseases 957
Countries citing papers authored by Raymond Evers
This map shows the geographic impact of Raymond Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Evers more than expected).
Fields of papers citing papers by Raymond Evers
This network shows the impact of papers produced by Raymond Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Evers. The network helps show where Raymond Evers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raymond Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 10 | |
| 3 | 2022 | 26 | |
| 4 | 2019 | 60 | |
| 5 | 2018 | 96 | |
| 6 | 2014 | 41 | |
| 7 | 2010 | 12 | |
| 8 | 2008 | 16 | |
| 9 | 2006 | 105 | |
| 10 | 2006 | 51 | |
| 11 | 2004 | 80 | |
| 12 | 2000 | 269 | |
| 13 | 2000 | 94 | |
| 14 | A Family of Drug Transporters: the Multidrug Resistance-Associated Proteinsbreakdown → | 2000 | 1386 |
| 15 | The multidrug resistance protein familybreakdown → | 1999 | 525 |
| 16 | 1997 | 112 | |
| 17 | 1996 | 224 | |
| 18 | 1996 | 65 | |
| 19 | 1990 | 24 | |
| 20 | 1989 | 24 |
About Raymond Evers
Raymond Evers is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 99 papers that have together received 9.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (59 papers), Pharmacological Effects and Toxicity Studies (38 papers), Pharmacogenetics and Drug Metabolism (29 papers), HIV/AIDS drug development and treatment (9 papers), Trypanosoma species research and implications (9 papers), Amino Acid Enzymes and Metabolism (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). The work is most often cited by research in Oncology (5.8k citations), Pharmacology (1.8k citations) and Pediatrics, Perinatology and Child Health (2.7k citations). Raymond Evers has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Piet Borst, Marcel Kool, Jan Wijnholds, Xiaoyan Chu, Liesbeth van Deemter, Kelly Bleasby, Balázs Sarkadi, Éva Bakos, Alfred H. Schinkel and András Váradi. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Nucleic Acids Research, Molecular Pharmacology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.